SG/CALL/BRISTOL-MYERS SQUIBB/70/0.1/20.06.25

SG/CALL/BRISTOL-MYERS SQUIBB/70/0.1/20.06.25 Share Price

DE000SW7MH19

Real-time Boerse Frankfurt Warrants 15:53:54 20/06/2024 BST
0.03 ^EUR	+7.14%

Current month	+7.69%
1 month	-20.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart SG/CALL/BRISTOL-MYERS SQUIBB/70/0.1/20.06.25

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024	12:00pm	BU
Bristol Myers: ex-CEO of Agilent joins Board of Directors	06-19	CF
Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors	06-18	BU
Bristol Myers Squibb Appoints Michael R. McMullen as Independent Director and Member of the Audit Committee, Effective July 1, 2024	06-18	CI

More news

Quotes 5-day view

Date	Price	Change
20/06/24	0.03	+7.14%
19/06/24	0.028	-3.45%
18/06/24	0.029	-3.33%
17/06/24	0.03	+11.11%
14/06/24	0.027	+17.39%

Real-time Boerse Frankfurt Warrants

Last update June 20, 2024 at 03:53 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Société Générale
WKN	SW7MH1
ISIN	DE000SW7MH19
Date issued	12/03/2024
Strike	70 $
Maturity	20/06/2025 (365 Days)
Parity	10 : 1
Emission price	0.16 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.18 €
Lowest since issue	0.02 €
Spread	0.01 €
Spread %	25.64%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company